Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A1 | P22736 | 1/20 | 0.57 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.57 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.57 |
| ▸ | IDO1 | P14902 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 5/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | GLA | P06280 | 1/20 | 0.52 |
| ▸ | CDC25B | P30305 | 3/20 | 0.51 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.51 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.49 |
| ▸ | WDR5 | P61964 | 1/20 | 0.48 |
| ▸ | LDHA | P00338 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29373697 | 1.00 | NR4A1 (0.57) | NR4A1NR4A2NR4A3IDO1MEN1 | |
| Hydrochloric Acid SCHEMBL5415206 | 0.98 | NR4A1 (0.55) | NR4A1NR4A2NR4A3IDO1MEN1 | |
| SCHEMBL13209727 | 0.83 | CNR2 (0.49) | NR4A1NR4A2NR4A3IDO1MEN1 | |
| SCHEMBL28750883 | 0.83 | CNR2 (0.47) | NR4A1NR4A2NR4A3IDO1MEN1 | |
| SCHEMBL9218777 | 0.82 | IDO1 (0.51) | NR4A1NR4A2NR4A3IDO1MEN1 | |
| SCHEMBL9038317 | 0.81 | CNR2 (0.45) | NR4A1NR4A2NR4A3IDO1MEN1 | |
| SCHEMBL8689978 | 0.80 | GAA (0.53) | MEN1KMT2AKDM4EALDH1A1CYP2C19 | |
| SCHEMBL28099759 | 0.80 | CNR2 (0.44) | NR4A1NR4A2NR4A3IDO1MEN1 | |
| SCHEMBL31533158 | 0.80 | NR4A1 (0.61) | NR4A1NR4A2NR4A3MEN1KMT2A | |
| SCHEMBL29838841 | 0.79 | PTPN1 (0.66) | NR4A1NR4A2NR4A3IDO1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 541 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119781246-A | Photosensitive polyimide resin composition, cured film, and preparation method and application thereof | 吉林奥来德光电材料股份有限公司 | 2025-04-08 | — | — | CN | claimed |
| CN-115010924-B | Photosensitive polyimide resin composition, polyimide resin film containing photosensitive polyimide resin composition and application of photosensitive polyimide resin composition | 吉林奥来德光电材料股份有限公司 | 2023-10-13 | — | — | CN | claimed |
| CN-115010924-A | Photosensitive polyimide resin composition, polyimide resin film containing same and application of polyimide resin film | 吉林奥来德光电材料股份有限公司 | 2022-09-06 | — | — | CN | claimed |
| EP-1630605-B1 | PHOTOSENSITIVE RESIN COMPOSITION | TORAY INDUSTRIES (JP) | 2017-10-11 | — | — | EP | claimed |
| WO-2008068621-A2 | COMBINATION PRODUCT WITH IDO INHIBITOR AND TUMOR TARGETED IFN-GAMMA | MOLMED SPA (IT) | 2008-06-12 | — | — | WO | claimed |
| EP-0856025-B1 | CHOLESTERIC PHASE-FORMING POLYMERS AND THEIR USE | CELANESE VENTURES GMBH (DE) | 2003-01-15 | — | — | EP | claimed |
| US-6355616-B1 | FUNGICIDE OLIGOPEOTIDES | XOMA (US) TECHNOLOGY LTD. | 2002-03-12 | — | — | US | claimed |
| WO-2001000671-A1 | DERIVATIVE COMPOUNDS | XOMA TECHNOLOGY LTD. (US) | 2001-01-04 | — | — | WO | claimed |
| JP-9003344-A | — | — | None | — | — | JP | disclosed |
| US-20260104641-A1 | NEGATIVE PHOTOSENSITIVE RESIN COMPOSITION, PATTERNING PROCESS METHOD FOR FORMING CURED FILM, INTERLAYER INSULATING FILM, SURFACE PROTECTIVE FILM, AND ELECTRONIC COMPONENT | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-04-16 | — | — | US | disclosed |
| EP-3906415-B1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR ENHANCING CD8+ T CELL-DEPENDENT IMMUNE RESPONSES IN SUBJECTS SUFFERING FROM CANCER | INST NAT SANTE RECH MED (FR) | 2026-04-15 | — | — | EP | disclosed |
| US-12583973-B2 | Polyimide-based polymer, positive photosensitive resin composition, negative photosensitive resin composition, patterning method, method for forming cured film, interlayer insulating film, surface protective film, and electronic component | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-03-24 | — | — | US | disclosed |
| US-20260061031-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DILATED CARDIOMYOPATHY | INST NAT SANTE RECH MED (FR) | 2026-03-05 | — | — | US | disclosed |
| US-20260035471-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR ENHANCING CD8+ T CELL-DEPENDENT IMMUNE RESPONSES IN SUBJECTS SUFFERING FROM CANCER | INST NAT SANTE RECH MED (FR) | 2026-02-05 | — | — | US | disclosed |
| EP-0541670-A4 | PHOSPHENE OXIDE-TERMINATED ALLENE-ENE-YNE DNA-CLEAVING, ANTITUMOR AND ANTIBIOTIC MOLECULES | — | 1993-06-16 | — | — | EP | disclosed |
| EP-0541670-A1 | PHOSPHENE OXIDE-TERMINATED ALLENE-ENE-YNE DNA-CLEAVING, ANTITUMOR AND ANTIBIOTIC MOLECULES | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1993-05-19 | — | — | EP | disclosed |
| EP-0541720-A1 | GOLFOMYCIN DERIVATIVES: NOVEL FUSED RING CYCLODECADIYNE DERIVATIVES | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1993-05-19 | — | — | EP | disclosed |
| US-5136099-A | GOLFOMYCIN DERIVATIVES: FUSED RING CYCLODECADIYNE DERIVATIVES HAVING DNA-CLEAVING PROPERTIES AND ANTITUMOR ACTIVITY | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1992-08-04 | — | — | US | disclosed |
| WO-1992002480-A1 | GOLFOMYCIN DERIVATIVES: NOVEL FUSED RING CYCLODECADIYNE DERIVATIVES | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1992-02-20 | — | — | WO | disclosed |
| WO-1992002227-A1 | PHOSPHENE OXIDE-TERMINATED ALLENE-ENE-YNE DNA-CLEAVING, ANTITUMOR AND ANTIBIOTIC MOLECULES | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1992-02-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260104641-A1 | NEGATIVE PHOTOSENSITIVE RESIN COMPOSITION, PATTERNING PROCESS METHOD FOR FORMING CURED FILM, INTERLAYER INSULATING FILM, SURFACE PROTECTIVE FILM, AND ELECTRONIC COMPONENT | ARCN1, PRDM9, LBR | NR4A1 589/4885NR4A2 963/4885NR4A3 1256/4885 |
| US-20260061031-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DILATED CARDIOMYOPATHY | CD274, PDCD1, ICOS | NR4A1 326/4885NR4A2 412/4885NR4A3 352/4885 |
| US-20260035471-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR ENHANCING CD8+ T CELL-DEPENDENT IMMUNE RESPONSES IN SUBJECTS SUFFERING FROM CANCER | CD274, PDCD1LG2, PDCD1 | NR4A1 76/4885NR4A2 68/4885NR4A3 82/4885 |
| US-12583973-B2 | Polyimide-based polymer, positive photosensitive resin composition, negative photosensitive resin composition, patterning method, method for forming cured film, interlayer insulating film, surface protective film, and electronic component | PRDM9, ARCN1, PUF60 | NR4A1 642/4885NR4A2 1062/4885NR4A3 1764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.